|
| Press Releases |
|
 |
|
| Monday, June 25, 2018 |
|
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").
more info >> |
|
| Thursday, June 14, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score(R) results of 11 to 25. more info >> |
|
| Wednesday, June 13, 2018 |
|
|
雅各臣汇报TAILORx研究结果 |
| 雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）为全球领先的基因型诊断检测供应商Genomic Health, Inc. （「基美健」﹔纳斯达克： GHDX）的香港及澳门独家分销商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或「TAILORx」研究报告 more info >> |
|
|
雅各臣匯報TAILORx研究結果 |
| 雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）為全球領先的基因型診斷檢測供應商Genomic Health, Inc. （「基美健」﹔納斯達克：GHDX）的香港及澳門獨家分銷商，欣然分享Trial Assigning IndividuaLized Options for Treatment (Rx)或 「TAILORx」研究報告 more info >> |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Jacobson Pharma Ranked No.1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
雅各臣获《FinanceAsia》杂志「2018年亚洲最佳企业选举」选为香港「最佳小型企业」首位 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）欣然宣布集团于亚洲权威财经杂志《FinanceAsia》举办的「2018年亚洲最佳企业选举」中，于香港「最佳小型企业」排名第一。 more info >> |
|
|
雅各臣獲《FinanceAsia》雜誌「2018年亞洲最佳企業選舉」選為香港「最佳小型企業」首位 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）欣然宣佈集團於亞洲權威財經雜誌《FinanceAsia》舉辦的「2018年亞洲最佳企業選舉」中，於香港「最佳小型企業」排名第一。 more info >> |
|
|
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
| Wednesday, December 20, 2017 |
|
|
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market |
| Jacobson Pharma Corporation Limited today announced that through its wholly-owned subsidiaries, Jacobson Medical (Hong Kong) Limited and Joyful Ascent Limited, it has entered into a Licensing Framework Agreement and a Capital Increase Agreement with a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. namely, Shanghai Henlius Biotech Inc., a technological leader in research and development of biosimilar antibody drugs in China. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
e& life joins Dubai FinTech Summit as a Powered By sponsor
Apr 19, 2024 11:31: JST
|
|
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 19, 2024 11:30 HKT/SGT
|
|
|
22nd Edition of Cyber Security Summit: Thailand to Convene Esteemed Panel of Industry Leaders
Apr 19, 2024 11:11: JST
|
|
|
朝雲集團（06601.HK）：穩健增長與高派息策略共驅，多家頭部券商給予增持評級
Apr 19, 2024 10:24 HKT/SGT
|
|
|
22nd Edition of Cyber Security Summit: Thailand to Convene Esteemed Panel of Industry Leaders
Apr 19, 2024 10:11 HKT/SGT
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 19, 2024 10:11 HKT/SGT
|
|
|
富士通、世界初 形式の異なる企業のデジタルアイデンティティー証明書を変換する技術を開発し欧州データスペースへの接続実証に成功
Apr 19, 2024 10:00: JST
|
|
|
Eesee Implements Blockpass for Compliance in Digital Assets Marketplace
Apr 19, 2024 10:00 HKT/SGT
|
|
|
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
|
|
|
Rapid Evolution in Philippines' BFSI Sector: BFSI IT Summit 2024 to Illuminate Transformation
Apr 19, 2024 09:02: JST
|
|
|
Rapid Evolution in Philippines' BFSI Sector: BFSI IT Summit 2024 to Illuminate Transformation
Apr 19, 2024 08:02 HKT/SGT
|
|
|
GLOBE LIFE (GL): Kaplan Fox & Kilsheimer LLP Investigates GLOBE LIFE and Encourages Investors to Contact the Firm
Apr 19, 2024 08:00 HKT/SGT
|
|
|
标题：巨星传奇：2023年IP业务收入同比增长82.9%
Apr 18, 2024 21:19 HKT/SGT
|
|
|
標題：巨星傳奇：2023年IP業務收入同比增長82.9%
Apr 18, 2024 21:17 HKT/SGT
|
|
|
e& life joins Dubai FinTech Summit as a Powered By sponsor
Apr 18, 2024 20:56 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
